HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of rabies biologics against Irkut virus isolated in China.

Abstract
An Irkut virus (IRKV) was recently isolated from a bat in China. The protective ability of rabies biologics available in the Chinese market and experimental biologics against the rabies virus (RABV) and IRKV were assessed in a hamster model via preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) experiments. The results demonstrated that a single dose of rabies vaccine did not induce adequate protection against IRKV infection. However, routine PrEP with three doses of vaccine induced complete protection against IRKV infection. Higher doses of RABV immunoglobulins and alpha interferon were required during PEP to protect hamsters against IRKV versus RABV infection. Experimental recombinant vaccines containing IRKV glycoproteins induced more-reliable protection against IRKV than against RABV infection. Those findings may be explained by limited cross-neutralization of these viruses (confirmed via in vitro tests) in conjunction with antigenic distances between RABV and IRKV. These results indicate that the development and evaluation of new biologics for PrEP and PEP are required to ensure sufficient protection against IRKV infection in China and other territories where this virus is present.
AuthorsYe Liu, Qi Chen, Fei Zhang, Shoufeng Zhang, Nan Li, Hai Lian, Ying Wang, Jinxia Zhang, Rongliang Hu
JournalJournal of clinical microbiology (J Clin Microbiol) Vol. 51 Issue 11 Pg. 3499-504 (Nov 2013) ISSN: 1098-660X [Electronic] United States
PMID23946522 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biological Products
  • Rabies Vaccines
Topics
  • Animals
  • Biological Products (administration & dosage)
  • China
  • Cricetinae
  • Cross Protection
  • Disease Models, Animal
  • Female
  • Lyssavirus (drug effects, isolation & purification)
  • Mesocricetus
  • Post-Exposure Prophylaxis
  • Rabies Vaccines (administration & dosage)
  • Rhabdoviridae Infections (prevention & control, virology)
  • Survival Analysis
  • Vaccination (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: